Michelle Rudek-Renaut

Associate Professor

If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Pharmacokinetics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Plasma (human) Chemical Compounds
Tandem Mass Spectrometry Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Liquid chromatography Chemical Compounds
Mass spectrometry Chemical Compounds
Liquid Chromatography Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2018

Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma

Rubinstein, P. G., Moore, P. C., Rudek, M. A., Henry, D. H., Ramos, J. C., Ratner, L., Reid, E., Sharon, E. & Noy, A., Mar 13 2018, In : AIDS. 32, 5, p. 605-611 7 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Cytochrome P-450 CYP3A

Muscadine grape skin extract (MPX) in men with biochemically recurrent prostate cancer: A randomized, multicenter, placebo-controlled clinical trial

Paller, C. J. , Zhou, X. C. , Heath, E. I. , Taplin, M. E. , Mayer, T. , Stein, M. N. , Bubley, G. J. , Pili, R. , Hudson, T. , Kakarla, R. , Abbas, M. M. , Anders, N. M. , Dowling, D. , King, S. , Bruns, A. B. , Wagner, W. D. , Drake, C. G. , Antonarakis, E. S. , Eisenberger, M. A. , Denmeade, S. R. & 3 others Rudek, M. A., Rosner, G. L. & Carducci, M. A., Jan 15 2018, In : Clinical Cancer Research. 24, 2, p. 306-315 10 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
Prostatic Neoplasms

Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)

Ramos, J. C., Sparano, J. A., Rudek, M. A., Moore, P. C., Cesarman, E., Reid, E. G., Henry, D., Ratner, L., Aboulafia, D., Lee, J. Y., Ambinder, R. F., Mitsuyasu, R. & Noy, A., Mar 1 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 3, p. 180-190.e2

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Human Herpesvirus 4
Non-Hodgkin's Lymphoma

Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure-FLT3 Relationship

on behalf of the ETCTN-6745 study team, Jul 1 2018, In : Clinical and Translational Science. 11, 4, p. 435-443 9 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Protein-Tyrosine Kinases
Extracellular Signal-Regulated MAP Kinases
Mitogen-Activated Protein Kinase 6

Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors

Kalin, J. H. , Wu, M. , Gomez, A. V. , Song, Y. , Das, J. , Hayward, D. , Adejola, N. , Wu, M. , Panova, I. , Chung, H. J. , Kim, E. , Roberts, H. J. , Roberts, J. M. , Prusevich, P. , Jeliazkov, J. R. , Roy Burman, S. S. , Fairall, L. , Milano, C. , Eroglu, A. , Proby, C. M. & 14 others Dinkova-Kostova, A. T., Hancock, W. W., Gray, J. J., Bradner, J. E., Valente, S., Mai, A., Anders, N. M., Rudek, M. A., Hu, Y., Ryu, B., Schwabe, J. W. R., Mattevi, A., Alani, R. M. & Cole, P. A., Dec 1 2018, In : Nature Communications. 9, 1, 53

Research output: Contribution to journalArticle

cells and cell components
Histone Demethylases
enzyme activity
Histone Deacetylase Inhibitors
gene expression